Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BRAFV600E‐PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterization

Clinical and Translational Medicine(2025)10.1002/ctm2.70251Source: DataRank Database

BRAFV600E‐PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterization is a research paper published in Clinical and Translational Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.11)OA: goldTopics (29)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Zakaria Y. Abd Elmageed ORCID,Youssef Errami ORCID,Guangdi Wang ORCID,Joe Abi‐Rached ORCID,Emad Kandil ORCID

Live enrichment

PubMed:40045459 OpenAlex:https://openalex.org/W4408232035

National Institutes of Health

Grant: NIH/NIGMS P30GM1017640

NIH/NIGMS

Grant: P30GM1017640

FWCI

2.11

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctm2.70251

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctm2.70251

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.70251

journalhttps://doi.org/10.1002/ctm2.70251

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40045459

Fields of Study

Protein Degradation and InhibitorsMelanoma and MAPK PathwaysChromatin Remodeling and CancerHumansMelanomaProto-Oncogene Proteins B-rafCell Line, TumorTranscriptomeProtein Kinase Inhibitors

MeSH Terms

HumansMelanomaCell Line, TumorProtein Kinase InhibitorsProto-Oncogene Proteins B-rafTranscriptome

Keywords

TranscriptomeMelanomaMedicineCancer researchComputational biologyBiologyGeneticsGeneGene expressionBRAFV600EMAPK pathwayMITFPROTACdifferentiation state